myelodysplastic syndromes (MDS) | Aplastic Anemia & MDS International Foundation

myelodysplastic syndromes (MDS)

Catherine Lai, MD, MPH

Lai, Catherine
Director of Leukemia
Washington Med Star Georgetown University Hospital

Catherine Lai, MD, MPH, is the director of Leukemia at MedStar Georgetown University Hospital’s Lombardi Comprehensive Cancer Center. Board certified in hematology, medical oncology, and internal medicine, Dr. Lai specializes in detecting, monitoring, and treating acute leukemia in adults. Previously at the National Institutes of Health (NIH), she focused on clinical trials in acute leukemias. Under Dr. Lai’s leadership, the leukemia program offers acute leukemia patients advanced and highly specialized care, including clinical trials with immunotherapy. Dr.

Young Enough to Undergo Allogeneic Transplantation for Myelodysplastic Syndromes?: Considering the Results of the Medicare Coverage With Evidence Development Study

Author(s): 
Franke GN, Kubasch AS, Platzbecker U
Primary Author: 
Franke GN
Journal Title: 
JAMA Oncology
Original Publication Date: 
Dec 2019
Bone Marrow Diseases: 

Myelodysplastic syndromes and the risk of cardiovascular disease in older adults: A SEER-medicare analysis

Author(s): 
Adrianzen Herrera D, Pradhan K, Snyder R, Karanth S, Janakiram M, Mantzaris I, Braunschweig I, Budhathoki A, Shah UA, Verma AK, Murthy SB, Shastri A
Primary Author: 
Adrianzen Herrera D
Journal Title: 
Leukemia
Original Publication Date: 
Dec 2019
Bone Marrow Diseases: 

Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes

Author(s): 
Fenaux P, Platzbecker U, Mufti GJ, Garcia-Manero G, Buckstein R, Santini V, Díez-Campelo M, Finelli C, Cazzola M, Ilhan O, Sekeres MA, Falantes JF, Arrizabalaga B, Salvi F, Giai V, Vyas P, Bowen D, Selleslag D, DeZern AE, Jurcic JG, Germing U
Primary Author: 
Fenaux P
Journal Title: 
The New England Journal of Medicine
Original Publication Date: 
Jan 2020

BACKGROUND:

Bone Marrow Diseases: 

Marlise Luskin, MD, MSCE

Luskin, Marlise
Physician
Dana Farber Cancer Institute

Dr. Luskin received her MD from the University of Pennsylvania Perelman School of Medicine in 2009. She completed residency training in Internal Medicine at Brigham and Women's Hospital, followed by a fellowship in Hematology and Oncology at the University of Pennsylvania. She joined Dana-Farber as a member of the Adult Leukemia program in 2016.